RANBAXY'S ON THE PROWL

Action in the Indian pharmaceutical industry seems to be revving up again. If insiders are to be believed, the sector may soon witness another big-ticket acquisition by Ranbaxy Laboratories. Coming closely on the heels of its $324-m acquisition of Romania's largest generic drug company, Terapia, Ranbaxy's latest move is likely to make industry observers sit up.

The Economic Times (http://economictimes.indiatimes.com/articleshow/1863416.cms)